Kymera Therapeutics logo
Kymera Therapeutics KYMR
$ 44.76 2.87%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Kymera Therapeutics ROCE Ratio 2011-2024 | KYMR

Annual ROCE Ratio Kymera Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-41.91 -32.9 -21.87 -16.31 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.31 -41.91 -28.25

Quarterly ROCE Ratio Kymera Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-38.18 -44.65 -47.17 -34.31 -43.06 -37.28 -37.57 -27.62 -33.55 -30.72 -30.05 -20.29 -23.14 -20.06 -15.48 -11.81 4.13 22.92 27.92 15.94 15.94 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
27.92 -47.17 -19.43